Pfizer Shares (PFE) Continue Strong Run Despite JP Morgan Downgrading the Stock


Pfizer’s stock continues on it’s winning run despite JP Morgan downgrading the stock earlier this week.

The stock moved 0.93% higher Thursday, to close the day at $44.57.

The stock recorded a trading volume of 22,404,093 shares, which was below its three months average volume of 22,696,423 shares.

In the last year, Pfizer’s shares have traded in a range of 33.20 – 46.47. The share price has gained 34.25% from its 52 week low.

Pfizer is known for it’s in-depth research and development area which has helped the company come out with top drugs over the years which have supported ever higher stock prices.

The company’s shares are currently trading above their 200-day moving average.

The stock’s 50-day moving average of $43.92 is above its 200-day moving average of $41.13. Shares of the company are trading at a Price to Earnings ratio of 11.26. Shares of Pfizer have gained roughly 2.41 percent in the past month and are up 23.05 percent year-to-date.


  1. Pfizer shouldn’t have to put up with silly banks like JP morgan saying such things about there stock. They are a good company and even older than JP.


Please enter your comment!
Please enter your name here